Exter Neil
- SEC CIK
- 0001620014
No open-market purchases or sales filed in the past year.
Current role at each company
- MAZE Maze Therapeutics, Inc.Directoras of Sep 24, 2025
- DBTX Decibel Therapeutics, Inc.Director, 10% Owneras of Jun 21, 2022
- PLRX Pliant Therapeutics, Inc.Directoras of Jun 21, 2022
- RVMD Revolution Medicines, Inc.Directoras of Jun 17, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Exter Neil as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RVMD Revolution Medicines, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2022 (view filing) | Jun 8 | 2 days | Exter NeilDirector | SSale | 0 | – | $0 | –0 after |